New assay developed for routine poultry monitoring In the journal Methods, scientists from Wageningen Bioveterinary Research report the development of a multiplex assay for avian influenza. The assay is built on Luminex’s xMAP® Technology, and allows for serotyping all 16 hemagglutinin (HA) and 9 neuraminidase (NA) protein subtypes simultaneously. Testing for avian influenza (AI) is […]
At Luminex, we often get caught up discussing the ins and outs of our instruments and assays, but the impact our employees have goes beyond the products we design. Where would we be without reliable facilities and high-functioning workspaces? Our Facilities team does an enormous amount of work to ensure everything from office spaces to […]
Single-plex targets developed will become components for future multiplex assays Scientists in the Waterboer lab at the German Cancer Institute have developed the building blocks for a multiplex assay that will make it possible to quickly interrogate a person’s history of infection and vaccination. In a paper from Methods, the team reports developing individual assays […]
Technique provides critical data for development of monoclonal antibodies and biosimilars At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), […]
A new technique eliminates the use of monoclonal antibodies and is robust enough for field use Monoclonal antibodies may soon become a thing of the past. While their high selectivity and affinity for their targets once made them the “gold standard” for detection applications, the time it takes to generate one and the variability in […]